CClinicalTrials.gg
CompletedNCT00537758Updated Mar 31, 2020

Treatment for Obesity and Binge Eating Disorder

An interventional study of Cognitive Behavior Therapy and CBT and BWL in Binge Eating Disorder and Obesity, sponsored by Yale University. Completed at 1 site in United States. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-03-31.

Sponsored by Yale University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
125
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

This study is a test of cognitive behavioral therapy(CBT) and behavioral weight loss (BWL) treatments for obese patients with binge eating disorder (BED). The study involves a comparison of three treatment conditions: (1) CBT; (2) BWL, and (3) a sequential (two-part) treatment consisting of CBT followed by BWL.

02

Conditions studied

  • Binge Eating Disorder
  • Obesity

Keywords

  • binge eating disorder
  • cognitive behavior therapy
  • combination therapy
  • obesity
  • weight loss
  • body weight
  • clinical trial
  • dietary restriction
  • overeating
  • weight control
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's enrollment of 125 is above the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Yale University is the lead sponsor of 1,724 studies on the registry; 298 are open to participants now.

Of its 210 completed or terminated interventional studies of FDA-regulated products, 126 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Binge Eating
  • Overweight

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Current cardiac disease
  • Serious neurologic illnesses
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
125 participants (actual)

Study arms

  • Experimental
    1

    Cognitive Behavior Therapy

    Behavioral: Cognitive Behavior Therapy

  • Experimental
    2

    Behavioral Weight Loss Treatment

    Behavioral: Behavioral Weight Loss Treatment

  • Experimental
    3

    CBT + BWL

    Behavioral: CBT and BWL

Interventions

  • BehavioralCognitive Behavior Therapy
  • BehavioralCBT and BWL
  • BehavioralBehavioral Weight Loss Treatment
06

What researchers measure

Primary outcomes

  1. Binge Eating

  2. BMI

07

Study locations

1 site
  • Yale Psychiatric Research at Congress Place
    New Haven, Connecticut 06519, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 31, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00537758
Lead sponsor
Yale University
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First posted
Oct 1, 2007
Start date
Jul 2002
Last update
Mar 31, 2020

Study contacts

Carlos M. Grilo, PhD
principal investigator · Yale University
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2007. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion